Persistent Depressive Disorders

J. Kim Penberthy

2019年5月 · Advances in Psychotherapy - Evidence-Based Practice 第 43 冊 · Hogrefe Publishing

電子書

106

頁數

符合資格

關於這本電子書

This compact guide is packed with the latest knowledge on the assessment and treatment of persistent depressive disorders (PDDs) – the new DSM-5 diagnosis that amalgamates the categories dysthymic disorder (DD), chronic major depression (MDD), and DD with major depressive episode (MDE). Written by a leading expert, the book guides us through the complexities of assessing PDDs and the models for understanding how these difficult-to-identify and potentially life-threatening disorders develop and are maintained over long periods. It then outlines those therapies that have the strongest evidence base. The author goes on to explore in detail the cognitive behavioral analysis system of psychotherapy (CBASP), a treatment specifically developed for PDDs. This compelling integrated approach incorporates components of learning, developmental, interpersonal, and cognitive theory with aspects of interpersonal mindfulness. We are led expertly through the therapeutic process using clinical vignettes and practical tips, with particular attention paid to identifying the assessment and therapy methods most valuable in CBASP. Printable tools in the appendices can be used in daily practice. This book will interest clinical psychologists, psychotherapists, psychiatrists, counselors, and students.

探索更多

關於作者

Dr. J. Kim Penberthy is the Chester F. Carlson Professor of Psychiatry & Neurobehavioral Sciences at the University of Virginia School of Medicine in Charlottesville, VA. She has spent her career treating patients with depressive disorders, training other professionals regarding effective treatments, and conducting research in the effective diagnosis and treatment of depression and related disorders. Dr. Penberthy is internationally known for her research regarding effective treatment for persistent depression and related disorders using the cognitive behavioral analysis system of psychotherapy (CBASP) and has developed applications for comorbidities and group administration.